Illness	Number of cases
Malignant neoplasm of bronchus and lung (C34.1)	224
Malignant neoplasm of bronchus and lung (C34.3)	143
Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs - Neoplasm of uncertain behavior of trachea bronchus and lung (D38.1)	136
Chronic obstructive pulmonary disease with acute exacerbation (J44.19)	103
Other chronic obstructive pulmonary disease (J44.80)	75
Chronic obstructive pulmonary disease with acute exacerbation (J44.10)	72
Sleep disorders - Primary central sleep apnea (G47.31)	71
Abnormal findings on diagnostic imaging of lung (R91)	71
Unspecified acute lower respiratory infection (J22)	63
Heart failure (I50.01)	50

Top 10 treatments

Treatment	Number
Measurement of lung function in an airtight cabin - whole body plethysmography (1-710)	969
Analysis of the amount of carbon monoxide taken in and given off by the lungs (1-711)	928
Examination of the trachea and the bronchi by endoscopy (1-620.0x)	693
Examination of the bronchi by taking a sample of fluid or tissue with a needle (1-843)	510
Examination of the trachea and the bronchi by endoscopy (1-620.00)	308
Installation and adjustment of a mechanical ventilator for home use (8-716.10)	269
Ultrasound of the lungs with access through the respiratory tract (3-05f)	264
Examination of the trachea and the bronchi by endoscopy (1-620.1x)	180
Taking a tissue sample (biopsy) of lymph nodes, spleen or thymus gland through the skin, guided by imaging procedures such as ultrasound (1-426.3)	173
Taking a tissue sample (biopsy) of the respiratory tract by endoscopy (1-430.10)	156

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 1400

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

Quality of participation in the Disease Management Programme (DMP)
No participation

Teilnahme an sonstigen Verfahren der externen vergleichenden Qualitätssicherung

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)
No participation

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
25	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
22	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
19	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility

Accessibility information

General information

Research & teaching

Job	Explanation
Project-related cooperation with colleges and universities
Lectureships / teaching posts at colleges and universities
Participation in multi-centre phase III/IV studies
Student training (clinical traineeship / internship year)
Doctoral supervision

Training

No.	Training in other healing professions	Comment
HB03	Physical therapist / physiotherapist (m/f)
HB01	Nurse and health care worker (m/f)
HB02	Health and paediatric nurse (m/f)
HB07	Surgical technical assistant (m/f)